Story perspectives

UK Ministers Under Fire Over Controversial US Medicine Deal

1/28/2026

27 3

Summary

Story summary

UK ministers face pressure to reveal details of a controversial deal with the US on medicine costs, labeled a "Trump shakedown of the NHS."
Opposition MPs demand an impact assessment, citing concerns that the deal could impose billions in additional NHS costs by 2035.
The Department of Health and Social Care (DHSC) states the deal will add £1 billion in costs from 2025 to 2028 but lacks long-term estimates.
Critics, including Liberal Democrat leader Ed Davey, accuse the government of secrecy and compromising NHS control, while the DHSC claims the deal enhances patient access to medicines.

1 of 1

Story summary

UK ministers face pressure to reveal details of a controversial deal with the US on medicine costs, labeled a "Trump shakedown of the NHS."
Opposition MPs demand an impact assessment, citing concerns that the deal could impose billions in additional NHS costs by 2035.
The Department of Health and Social Care (DHSC) states the deal will add £1 billion in costs from 2025 to 2028 but lacks long-term estimates.
Critics, including Liberal Democrat leader Ed Davey, accuse the government of secrecy and compromising NHS control, while the DHSC claims the deal enhances patient access to medicines.